{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T23:06:40Z","timestamp":1768777600326,"version":"3.49.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/s10157-009-0213-3","type":"journal-article","created":{"date-parts":[[2009,7,23]],"date-time":"2009-07-23T05:00:39Z","timestamp":1248325239000},"page":"663-666","source":"Crossref","is-referenced-by-count":5,"title":["Successful effect of triple blockade of renin\u2013angiotensin\u2013aldosterone system on massive proteinuria in a patient with chronic kidney disease"],"prefix":"10.1007","volume":"13","author":[{"given":"Satoru","family":"Kuriyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Sugano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Go","family":"Kanzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Hosoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,12,1]]},"reference":[{"key":"213_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1053\/ajkd.2001.25176","volume":"38","author":"D Russo","year":"2001","unstructured":"Russo D, Minutolo R, Pisani A, Esposito R, Signoriello G, Andreucci M, et\u00a0al. Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy. Am J Kidney Dis. 2001;38:18\u201325.","journal-title":"Am J Kidney Dis"},{"key":"213_CR2","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S0272-6386(99)70416-6","volume":"33","author":"D Russo","year":"1999","unstructured":"Russo D, Pisani A, Belletta MM, De Nicola L, Savino FA, Andreucci M, et\u00a0al. Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy. Am J Kidney Dis. 1999;33:851\u20136.","journal-title":"Am J Kidney Dis"},{"key":"213_CR3","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1159\/000045855","volume":"86","author":"S Kuriyama","year":"2000","unstructured":"Kuriyama S, Tomonari H, Abe A, Imasawa T, Hosoya T. Beneficial effect of combination therapy with angiotensin\u00a0II receptor antagonist and angiotensin converting enzyme inhibitor on overt proteinuria in a patient with type I diabetic nephropathy. Nephron. 2000;86:529\u201330.","journal-title":"Nephron"},{"key":"213_CR4","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1136\/bmj.321.7274.1440","volume":"321","author":"CE Mogensen","year":"2000","unstructured":"Mogensen CE, Neldam S, Tikkanen I, Oren S, Viskoper R, Watts RW, et\u00a0al. Randomized controlled trial of dual blockade of renin angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study. Brit Med J. 2000;321:1440\u20134.","journal-title":"Br Med J"},{"key":"213_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0140-6736(03)12229-5","volume":"361","author":"N Nakao","year":"2003","unstructured":"Nakao N, Yoshimura A, Morita H, Takada M, Kayano T, Ideura T. Combination treatment of angiotensin\u00a0II receptor blocker and angiotensin converting enzyme inhibitor in non-diabetic renal disease COOPERATE: a randomized controlled trial. Lancet. 2003;361:117\u201324.","journal-title":"Lancet"},{"key":"213_CR6","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S0140-6736(08)61236-2","volume":"372","author":"JF Mann","year":"2008","unstructured":"Mann JF, Schmieder RE, McQueen M, Dyal L, Schumacher H, Pogue J, et\u00a0al. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomized, double-blind, controlled trial. Lancet. 2008;372:547\u201353.","journal-title":"Lancet"},{"key":"213_CR7","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/00004872-200103001-00017","volume":"19","author":"Y Takeda","year":"2001","unstructured":"Takeda Y, Yoneda T, Demura M, Furukawa K, Miyamori I, Mabuchi H. Effects of sodium intake on cardiovascular aldosterone synthesis in stroke-prone spontaneously hypertensive rats. J Hypertens. 2001;19:635\u20139.","journal-title":"J Hypertens"},{"key":"213_CR8","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1161\/HYPERTENSIONAHA.107.091058","volume":"50","author":"M Nagase","year":"2007","unstructured":"Nagase M, Matsui H, Shibata S, Gotoda T, Fujita T. Salt-induced nephropathy in obese spontaneously hypertensive rats via paradoxical activation of the mineralocorticoid receptor: Role of oxidative stress. Hypertension. 2007;50:877\u201383.","journal-title":"Hypertension"},{"key":"213_CR9","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1038\/sj.ki.5001854","volume":"70","author":"S Bianchi","year":"2006","unstructured":"Bianchi S, Bigazzi R, Campese VM. Long-term effect of spironolactone on proteinuria and kidney function in patients with chronic kidney disease. Kidney Int. 2006;70:2116\u201323.","journal-title":"Kidney Int"},{"key":"213_CR10","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1111\/j.1523-1755.2005.00756.x","volume":"68","author":"KJ Schjoedt","year":"2005","unstructured":"Schjoedt KJ, Rossing K, Juhl TR, Boomsma F, Tarnow L, Rossing P, et\u00a0al. Beneficial impact of spironolactone in diabetic nephropathy. Kidney Int. 2005;68:2829\u201336.","journal-title":"Kidney Int"},{"key":"213_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1291\/hypres.31.59","volume":"31","author":"Y Furumatsu","year":"2008","unstructured":"Furumatsu Y, Nagasawa Y, Tomida K, Mikami S, Kaneko T, Okada N, et\u00a0al. Effect of renin angiotensin aldosterone system triple blockade on non-diabetic renal disease: Addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin converting enzyme inhibitor with an angiotensin\u00a0II receptor blocker. Hypertens Res. 2008;31:59\u201367.","journal-title":"Hypertens Res"},{"key":"213_CR12","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1053\/j.ajkd.2008.02.297","volume":"52","author":"L Tylicki","year":"2008","unstructured":"Tylicki L, Rutkowski P, Renke M, Larcznski W, Aleksandrowicz E, Lysiak-Szydlowska W, et\u00a0al. Triple pharmacological blockade of the renin angiotensin aldosterone system in non-diabetic CKD: An open-label crossover randomized controlled trial. Am J Kidney Dis. 2008;52:486\u201393.","journal-title":"Am J Kidney Dis"},{"key":"213_CR13","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/j.1440-1681.2004.04079.x","volume":"31","author":"F Rogerson","year":"2004","unstructured":"Rogerson F, Yao Y, Smith BJ, Fuller PJ. Differences in the determinants of eplerenone, spironolactone and aldosterone binding to the mineralocorticoid receptor. Clin Exp Pharmacol Physiol. 2004;31:704\u20139.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"213_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.mce.2003.10.005","volume":"217","author":"SM Garthwaite","year":"2004","unstructured":"Garthwaite SM, McMahon EG. The evolution of aldosterone antagonists. Mol Cell Endocrinol. 2004;217:27\u201331.","journal-title":"Mol Cell Endocrinol"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-009-0213-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-009-0213-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-009-0213-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-009-0213-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T20:23:41Z","timestamp":1559161421000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-009-0213-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["213"],"URL":"https:\/\/doi.org\/10.1007\/s10157-009-0213-3","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}